Yüklüyor......
Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence
Chronic hepatitis C virus (HCV) infection with advanced cirrhosis or post‐liver transplantation recurrence represents a high unmet medical need with no approved therapies effective across all HCV genotypes. The open‐label ALLY‐1 study assessed the safety and efficacy of a 60‐mg once‐daily dosage of...
Kaydedildi:
| Yayımlandı: | Hepatology |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5069651/ https://ncbi.nlm.nih.gov/pubmed/26754432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.28446 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|